127 related articles for article (PubMed ID: 12421573)
1. The negative immunoregulatory effects of serotonin (5-HT) moduline, an endogenous 5-HT1B receptor antagonist with anti-anxiety properties.
Maes M; Kenis G; Bosmans E
Cytokine; 2002 Sep; 19(6):308-11. PubMed ID: 12421573
[TBL] [Abstract][Full Text] [Related]
2. Specific interaction of 5-HT-moduline with human 5-HT1b as well as 5-HT1d receptors expressed in transfected cultured cells.
Rousselle JC; Plantefol M; Fillion MP; Massot O; Pauwels PJ; Fillion G
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):279-86. PubMed ID: 9774213
[TBL] [Abstract][Full Text] [Related]
3. The proliferation of human T lymphoblastic cells induced by 5-HT1B receptors activation is regulated by 5-HT-moduline.
Sibella-Argüelles C
C R Acad Sci III; 2001 Apr; 324(4):365-72. PubMed ID: 11386084
[TBL] [Abstract][Full Text] [Related]
4. 5-HT-moduline, a 5-HT(1B/1D) receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis.
Bentué-Ferrer D; Reymann JM; Rousselle JC; Massot O; Bourin M; Allain H; Fillion G
Eur J Pharmacol; 1998 Oct; 358(2):129-37. PubMed ID: 9808261
[TBL] [Abstract][Full Text] [Related]
5. 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice.
Sarhan H; Grimaldi B; Hen R; Fillion G
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):12-8. PubMed ID: 10651141
[TBL] [Abstract][Full Text] [Related]
6. Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze.
Clénet F; Hascoët M; Fillion G; Galons H; Bourin M
Behav Brain Res; 2005 Mar; 158(2):339-48. PubMed ID: 15698901
[TBL] [Abstract][Full Text] [Related]
7. Molecular, cellular and physiological characteristics of 5-HT-moduline, a novel endogenous modulator of 5-HT1B receptor subtype.
Massot O; Rousselle JC; Grimaldi B; Cloëz-Tayarani I; Fillion MP; Plantefol M; Bonnin A; Prudhomme N; Fillion G
Ann N Y Acad Sci; 1998 Dec; 861():174-82. PubMed ID: 9928255
[TBL] [Abstract][Full Text] [Related]
8. Effects of physical training on functional activity of 5-HT1B receptors in rat central nervous system: role of 5-HT-moduline.
Chennaoui M; Grimaldi B; Fillion MP; Bonnin A; Drogou C; Fillion G; Guezennec CY
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):600-4. PubMed ID: 10882034
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors.
Cloëz-Tayarani I; Cardona A; Rousselle JC; Massot O; Edelman L; Fillion G
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9899-904. PubMed ID: 9275223
[TBL] [Abstract][Full Text] [Related]
10. Acute stress induces a differential increase of 5-HT-moduline (LSAL) tissue content in various rat brain areas.
Bonnin A; Grimaldi B; Fillion MP; Fillion G
Brain Res; 1999 Apr; 825(1-2):152-60. PubMed ID: 10216182
[TBL] [Abstract][Full Text] [Related]
11. In humans, corticotropin releasing hormone antagonizes some of the negative immunoregulatory effects of serotonin.
Maes M; Kenis G; Kubera M
Neuro Endocrinol Lett; 2003 Dec; 24(6):420-4. PubMed ID: 15073568
[TBL] [Abstract][Full Text] [Related]
12. Effect of 5-HT-moduline, an endogenous peptide, in associative learning.
Hong E; Orozco G; Meneses A; Fillion G
Proc West Pharmacol Soc; 1999; 42():37-8. PubMed ID: 10697683
[No Abstract] [Full Text] [Related]
13. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
Massot O; Rousselle JC; Fillion MP; Grimaldi B; Cloëz-Tayarani I; Fugelli A; Prudhomme N; Seguin L; Rousseau B; Plantefol M; Hen R; Fillion G
Mol Pharmacol; 1996 Oct; 50(4):752-62. PubMed ID: 8863819
[TBL] [Abstract][Full Text] [Related]
14. A new peptide, 5-HT-moduline, isolated and purified from mammalian brain specifically interacts with 5-HT1B/1D receptors.
Fillion G; Rousselle JC; Massot O; Zifa E; Fillion MP; Prudhomme N
Behav Brain Res; 1996; 73(1-2):313-17. PubMed ID: 8788526
[TBL] [Abstract][Full Text] [Related]
15. 5-HT moduline: an endogenous inhibitor of 5-HT(1B/1D)-mediated contraction in pulmonary arteries.
Murdoch R; Morecroft I; MacLean MR
Br J Pharmacol; 2003 Mar; 138(5):795-800. PubMed ID: 12642380
[TBL] [Abstract][Full Text] [Related]
16. 5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus.
Daws LC; Gerhardt GA; Frazer A
Neurosci Lett; 1999 May; 266(3):165-8. PubMed ID: 10465699
[TBL] [Abstract][Full Text] [Related]
17. Potential of 5-HT-moduline as a drug target for affective disorders.
Fillion G
Curr Opin Investig Drugs; 2000 Sep; 1(1):104-9. PubMed ID: 11249585
[TBL] [Abstract][Full Text] [Related]
18. The role and therapeutic potential of 5-HT-moduline in psychiatry.
Moret C; Grimaldi B; Massot O; Fillion G
Semin Clin Neuropsychiatry; 2003 Apr; 8(2):137-46. PubMed ID: 12728412
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic profile of HG1, a 5-HT-moduline antagonist, in three mouse models of anxiety.
Clénet F; Hascoët M; Fillion G; Galons H; Bourin M
Eur Neuropsychopharmacol; 2004 Dec; 14(6):449-56. PubMed ID: 15589384
[TBL] [Abstract][Full Text] [Related]
20. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10.
Kubera M; Kenis G; Bosmans E; Scharpé S; Maes M
Neuropsychopharmacology; 2000 Jul; 23(1):89-98. PubMed ID: 10869889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
